Rhythm Pharmaceuticals In...

NASDAQ: RYTM · Real-Time Price · USD
63.32
0.59 (0.94%)
At close: Jun 30, 2025, 3:59 PM
62.21
-1.75%
After-hours: Jun 30, 2025, 05:54 PM EDT
0.94%
Bid 61.01
Market Cap 4.03B
Revenue (ttm) 136.86M
Net Income (ttm) -170.02M
EPS (ttm) -2.8
PE Ratio (ttm) -22.61
Forward PE -44.51
Analyst Strong Buy
Ask 64
Volume 584,142
Avg. Volume (20D) 728,991
Open 63.66
Previous Close 62.73
Day's Range 62.29 - 64.00
52-Week Range 40.46 - 69.89
Beta 2.30

About RYTM

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RYTM
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RYTM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Rhythm Pharmaceuticals Inc. is scheduled to release its earnings on Aug 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+5.04%
Rhythm Pharmaceuticals shares are trading higher a... Unlock content with Pro Subscription
2 months ago
+17.06%
Rhythm Pharmaceuticals shares are trading higher after the company announced that the Phase 3 TRANSCEND trial met its primary endpoint.